BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 8282778)

  • 1. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
    Levi M; van Der POLL T; ten CATE H; Kuipers B; Biemond BJ; Jansen HM; ten CATE JW
    Am J Respir Crit Care Med; 1998 Jul; 158(1):92-8. PubMed ID: 9655712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
    Biemond BJ; Levi M; Ten Cate H; Van der Poll T; Büller HR; Hack CE; Ten Cate JW
    Clin Sci (Lond); 1995 May; 88(5):587-94. PubMed ID: 7614818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; Hack CE; ten Cate H; van Deventer SJ; Eerenberg AJ; de Groot ER; Jansen J; Gallati H; Büller HR
    J Exp Med; 1994 Apr; 179(4):1253-9. PubMed ID: 8145042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; van Deventer SJ; ten Cate H; Haagmans BL; Biemond BJ; Büller HR; Hack CE; ten Cate JW
    Blood; 1994 Jan; 83(2):446-51. PubMed ID: 8286742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees.
    Moons AH; Peters RJ; Cate Ht; Bauer KA; Vlasuk GP; Büller HR; Levi M
    Thromb Haemost; 2002 Oct; 88(4):627-31. PubMed ID: 12362234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
    Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
    Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.
    Derhaschnig U; Bergmair D; Marsik C; Schlifke I; Wijdenes J; Jilma B
    Crit Care Med; 2004 May; 32(5):1136-40. PubMed ID: 15190963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.
    van Deventer SJ; Büller HR; ten Cate JW; Aarden LA; Hack CE; Sturk A
    Blood; 1990 Dec; 76(12):2520-6. PubMed ID: 2124934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
    Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
    Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat emulsion infusion potentiates coagulation activation during human endotoxemia.
    van der Poll T; Coyle SM; Levi M; Boermeester MA; Braxton CC; Jansen PM; Hack CE; Lowry SF
    Thromb Haemost; 1996 Jan; 75(1):83-6. PubMed ID: 8713784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.
    de Pont AC; Moons AH; de Jonge E; Meijers JC; Vlasuk GP; Rote WE; Büller HR; van der Poll T; Levi M
    J Thromb Haemost; 2004 Jan; 2(1):65-70. PubMed ID: 14717968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
    Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
    J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
    van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
    Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
    Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
    van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer SJ; Hack CE; Aarden LA; ten Cate JW
    J Immunol; 1993 Aug; 151(4):2318-25. PubMed ID: 8345209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous extract from Brownea grandiceps flowers with effect on coagulation and fibrinolytic system.
    Pereira B; Brazón J
    J Ethnopharmacol; 2015 Feb; 160():6-13. PubMed ID: 25460592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.